These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 7543725

  • 1. Rapamycin: a bone sparing immunosuppressant?
    Romero DF, Buchinsky FJ, Rucinski B, Cvetkovic M, Bryer HP, Liang XG, Ma YF, Jee WS, Epstein S.
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [Abstract] [Full Text] [Related]

  • 2. The role of testosterone in cyclosporine-induced osteopenia.
    Bowman AR, Sass DA, Dissanayake IR, Ma YF, Liang H, Yuan Z, Jee WS, Epstein S.
    J Bone Miner Res; 1997 Apr; 12(4):607-15. PubMed ID: 9101372
    [Abstract] [Full Text] [Related]

  • 3. Influence of age on cyclosporin A-induced alterations in bone mineral metabolism in the rat in vivo.
    Katz I, Li M, Joffe I, Stein B, Jacobs T, Liang XG, Ke HZ, Jee W, Epstein S.
    J Bone Miner Res; 1994 Jan; 9(1):59-67. PubMed ID: 8154310
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Lack of change of cancellous bone volume with short-term use of the new immunosuppressant rapamycin in rats.
    Joffe I, Katz I, Sehgal S, Bex F, Kharode Y, Tamasi J, Epstein S.
    Calcif Tissue Int; 1993 Jul; 53(1):45-52. PubMed ID: 8348384
    [Abstract] [Full Text] [Related]

  • 6. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat.
    Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS.
    J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined flurbiprofen and cyclosporin-A does not attenuate bone loss and exaggerates renal impairment.
    Sass DA, Rucinski B, Bryer HP, Mann GN, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1996 Oct; 19(4):381-6. PubMed ID: 8894144
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat.
    Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS.
    Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952
    [Abstract] [Full Text] [Related]

  • 11. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N, Torras J, Alperovich G, Cruzado JM, Giménez-Bonafé P, Herrero-Fresneda I, Franquesa Ml, Rama I, Grinyó JM.
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B, Weber E, Mihatsch MJ.
    Exp Nephrol; 1994 Oct; 2(6):324-33. PubMed ID: 7532090
    [Abstract] [Full Text] [Related]

  • 13. Alendronate prevents cyclosporin A-induced osteopenia in the rat.
    Sass DA, Bowman AR, Yuan Z, Ma Y, Jee WS, Epstein S.
    Bone; 1997 Jul; 21(1):65-70. PubMed ID: 9213009
    [Abstract] [Full Text] [Related]

  • 14. Effects of cerivastatin on vascularized allogenic bone transplantation in rats treated with cyclosporine A.
    Ohno T, Shigetomi M, Ihara K, Ikeda K, Tsubone T, Matsunaga T, Sugiyama T, Kawai S.
    Calcif Tissue Int; 2003 Jan; 72(1):50-6. PubMed ID: 12384812
    [Abstract] [Full Text] [Related]

  • 15. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH, Liang YX, Chen LQ, Liang JJ, Zhang J, Qiu J, Li WL, Hu JB, Xie KJ, Zhong WD, Chen LZ, Zheng KL.
    Zhonghua Yi Xue Za Zhi; 2007 Aug 28; 87(32):2235-7. PubMed ID: 18001539
    [Abstract] [Full Text] [Related]

  • 16. Raloxifene analog (LY117018 HCL) ameliorates cyclosporin A-induced osteopenia in oophorectomized rats.
    Bowman AR, Sass DA, Marshall I, Ma YF, Liang H, Jee WS, Epstein S.
    J Bone Miner Res; 1996 Aug 28; 11(8):1191-8. PubMed ID: 8854256
    [Abstract] [Full Text] [Related]

  • 17. Prostaglandin E2 alleviates cyclosporin A-induced bone loss in the rat.
    Katz IA, Jee WS, Joffe II, Stein B, Takizawa M, Jacobs TW, Setterberg R, Lin BY, Tang LY, Ke HZ.
    J Bone Miner Res; 1992 Oct 28; 7(10):1191-200. PubMed ID: 1456087
    [Abstract] [Full Text] [Related]

  • 18. The endothelin receptor antagonist, L-754,142 does not prevent cyclosporine A-induced osteopenia in rats.
    Sodam BR, Awumey EM, Sampson WH, Epstein S.
    Calcif Tissue Int; 2001 Feb 28; 68(2):117-21. PubMed ID: 11310347
    [Abstract] [Full Text] [Related]

  • 19. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat.
    Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S.
    J Lab Clin Med; 1990 Jan 28; 115(1):62-8. PubMed ID: 2299257
    [Abstract] [Full Text] [Related]

  • 20. Regulation of bone metabolism in immunosuppressant (FK506)-treated rats.
    Kirino S, Fukunaga J, Ikegami S, Tsuboi H, Kimata M, Nakata N, Nakano M, Ueno T, Mizukawa N, Sugahara T.
    J Bone Miner Metab; 2004 Jan 28; 22(6):554-60. PubMed ID: 15490265
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.